March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Phenotypes of Diabetic Retinopathy Progression to CSME based on Non-Invasive Examinations
Author Affiliations & Notes
  • Sandrina Nunes
    AIBILI, Coimbra, Portugal
  • Torcato Santos
    AIBILI, Coimbra, Portugal
  • Luisa Ribeiro
    AIBILI, Coimbra, Portugal
  • Conceição Lobo
    AIBILI, Coimbra, Portugal
    Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal
  • Rui Bernardes
    AIBILI, Coimbra, Portugal
    Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal
  • José Cunha-Vaz
    AIBILI, Coimbra, Portugal
  • Footnotes
    Commercial Relationships  Sandrina Nunes, None; Torcato Santos, None; Luisa Ribeiro, None; Conceição Lobo, None; Rui Bernardes, None; José Cunha-Vaz, None
  • Footnotes
    Support  PTDC/SAU-OSM/103226/2008
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2860. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sandrina Nunes, Torcato Santos, Luisa Ribeiro, Conceição Lobo, Rui Bernardes, José Cunha-Vaz; Phenotypes of Diabetic Retinopathy Progression to CSME based on Non-Invasive Examinations. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2860.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To test a predictive model for retinopathy progression in patients with diabetes type-2 using non-invasive examinations.

Methods: : Four-hundred and twelve type-2 diabetic patients with mild non-proliferative diabetic retinopathy (NPDR) were included in this 2-years observational and prospective study.Three hundred seventy-six patients completed the first 6-month of follow-up and underwent: color fundus photography, retinal thickness (RT) measurements and blood tests. Patients were followed until they develop clinically significant macular edema (CSME) or until the 24-month examination.Microaneurysm (MA) Turnover (Formation + Disappearance rates) was computed from color fundus photographs using the RetmarkerDR (Critical Health). RT maps (Stratus OCT, Zeiss) were computed using proprietary software.Patients were classified based on the initial 6-months period by MA Turnover (≥ 9), maximal RT increase (≥ 10% than normal RT) and increased macular area RT (≥ 5% of the central 1500 micr. in diameter area) into one of the 3 phenotypes of DR progression:- Phenotype 1: low MA Turnover and no RT increase;- Phenotype 2: low MA Turnover and increased RT and;- Phenotype 3: high MA Turnover.

Results: : One hundred and fifty six (44.8%), 97 (27.9%) and 95 (27.3%) patients were classified respectively in Phenotypes 1, 2 and 3.Three patients classified as Phenotype 1, 12 classified as Phenotype 2 and 19 patients classified as Phenotype 3 developed CSME (P<0.001). Patients classified as Phenotypes 2 and 3 presents a higher risk for CSME development than patients classified as Phenotype 1 (for Phenotype 2 OR=7.219 and for Phenotype 3 OR=12.771; P<0.001).

Conclusions: : This study shows that it is possible to identify three different phenotypes of mild NPDR using non-invasive examinations being these phenotypes predictive CSME development.

Clinical Trial: : http://www.clinicaltrials.gov NCT01228981

Keywords: diabetic retinopathy • imaging/image analysis: clinical • clinical (human) or epidemiologic studies: biostatistics/epidemiology methodology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×